Analysis of the heterogeneity of the binding site specificities of hyperimmune human anti-A and -A, B sera: the application of competition assays using murine monoclonal antibodies.

Vox Sanguinis
A Lubenko, J Savage

Abstract

Monoclonal antibodies PL41 and AL62 have previously been shown to recognize two distinct blood group A epitopes on the red cell surface. Competitive inhibition of the binding of 125I-PL41 and 125I-AL62 to group A1 red cells, by hyperimmune polyclonal human antibodies, has been employed to investigate the binding site specificities of 15 anti-A and 8 anti-A,B sera. Differences in the degree of inhibition of the binding of the two MABs by individual anti-A or -A,B samples indicate that polyclonal reagents are composed of varying proportions of up to 3 (or more) different antibody specificities, each recognizing a distinct epitope: PL41-like, AL62-like and a third (as yet undefined) category of antibody. In general, those anti-A sera with PL41-like specificities are superior agglutinators of A2B cells with weakly expressed A antigens; similarly, the specificity of potent anti-A,B, sera capable of strongly agglutinating Ax cells was likewise directed towards PL41-binding blood group A trisaccharide haptens.

References

Feb 28, 1978·Biochemical and Biophysical Research Communications·P J Fraker, J C Speck
Jul 1, 1988·European Journal of Haematology·H E HeierE Falleth
Dec 1, 1987·Revue française de transfusion et immuno-hématologie·P GaneR Oriol
Nov 15, 1972·Biochemical and Biophysical Research Communications·S HakomoriK Watanabe
Dec 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·K O Lloyd, E A Kabat
Apr 25, 1980·Biochimica Et Biophysica Acta·K K Karhi, C G Gahmberg

❮ Previous
Next ❯

Citations

Mar 8, 2008·Virology Journal·Karoline BragstadAnders Fomsgaard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.